Home - Blockchain - Coincheck on Nasdaq Through $1.25 Billion SPAC Merger


March 22, 2022

Coincheck on Nasdaq Through $1.25 Billion SPAC Merger

Coincheck, a Japanese cryptocurrency and digital asset exchange, is slated to combine with Thunder Bridge Capital Partners IV in a $1.25 billion transaction to go public on the Nasdaq, marking a rare blank-check firm deal in the turbulent market of 2022.

Thunder Bridge, a special-purpose acquisition company, or SPAC, said on Tuesday that it has agreed to merge with Coincheck and list on the Nasdaq Global Select Market by the end of 2022, subject to shareholder and regulatory clearance.

Coincheck is anticipated to go public under the ticker symbol “CNCK.” Thunder Bridge Capital Partners IV (ticker: THCP) shares rose 1.4 percent in early trade in the United States. Monex Group (8698.Japan), Coincheck’s parent firm, saw its shares increase 2.6 percent in Tokyo trade before the acquisition was announced in a news release.

Following the deal, which Thunder Bridge estimated to be worth $1.25 billion, Monex would hold 82 percent of the merged firm, which will be overseen by Oki Matsumoto as executive chair and Thunder Bridge CEO Gary Simanson. Thunder Bridge’s cash holdings of $237 million will also be transferred to the merged business as part of the agreement.

Coincheck, based in Tokyo, is one of Japan’s leading digital asset markets and is regulated by the country’s Financial Services Agency. According to Thunder Bridge, Coincheck has 1.5 million verified consumers and administers a platform with the widest and most extensive selection of tokens accessible in Japan.

“We are excited to partner with Monex to bring Coincheck into the U.S. public markets to facilitate its next stage of growth, and to further unlock the crypto economy for customers and institutions in Japan. We are also excited to work with Oki and his team to build a global digital platform under the Coincheck brand.”

Thunder Bridge and Coincheck together constitute an unusual SPAC deal this year. This sort of merger, in which a publicly traded blank-check company merges with an existing private corporation, exploded in popularity in 2020 but has completely faded by 2022.

Also Read:  Paying For Genetic Data with Cryptocurrency. How Pharma is using Blockchain Technology?